文献速递睡眠呼吸障碍鼻科

过敏性鼻炎与CPAP新使用者鼻塞变化的相关性

Association of Allergic Rhinitis With Change in Nasal Congestion in New Continuous Positive Airway Pressure Users.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2020-01-01

这项前瞻性队列研究纳入102例新诊断阻塞性睡眠呼吸暂停患者,比较过敏性鼻炎、非过敏性鼻炎和无鼻炎者接受CPAP治疗3个月后鼻塞的变化。全队列鼻塞改善,但过敏性鼻炎亚组改善程度显著小于无鼻炎组。

要点

  • CPAP治疗3个月后全队列鼻塞主观评分改善。
  • 基线过敏性鼻炎者鼻塞改善程度显著小于无鼻炎者。
  • 基线过敏性鼻炎可能预测CPAP相关鼻塞加重风险。

核心结论

  • CPAP治疗启动与主观鼻塞改善相关,但基线过敏性鼻炎患者改善较少。
  • 基线过敏性鼻炎可能预测哪些患者更易受CPAP潜在充血效应影响。

研究设计与样本

  • 前瞻性队列研究,纳入三级睡眠中心新诊断阻塞性睡眠呼吸暂停且诊断后3个月使用CPAP的连续患者。
  • 共102例参与者,男性61例(60%),平均(SD)年龄50(13)岁。
  • 基线鼻炎状态根据问卷和既往过敏测试分为过敏性鼻炎23例(22.5%)、非过敏性鼻炎67例(65.7%)和无鼻炎12例(11.8%)。
  • 数据收集于2004年至2008年,分析于2019年7月至2020年2月。

主要发现

  • 全队列鼻塞从基线至3个月改善:NOSE评分均值(SD)从38(26)降至27(23),平均(SD)变化-10(23),95%CI -15至-6。
  • 全队列VAS评分均值(SD)从41(27)降至32(28),平均(SD)变化-10(26),95%CI -15至-4。
  • 每个鼻炎亚组内鼻塞均改善。
  • 调整后,过敏性鼻炎亚组3个月鼻塞改善显著少于无鼻炎亚组:NOSE评分差异14(95%CI 1至28),VAS评分差异15(95%CI 0至30),正值表示改善较少。

关键数值与推荐

  • 鼻塞采用NOSE量表和VAS评估,各评分0至100,100为最严重鼻塞。
  • 亚组内变化用配对t检验,亚组间比较用多变量线性回归。

临床怎么用

  • 对计划启动CPAP的阻塞性睡眠呼吸暂停患者,应评估基线过敏性鼻炎状态。
  • 基线过敏性鼻炎患者可能需要关注CPAP治疗初期的鼻塞变化和依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Nasal congestion occurring after continuous positive airway pressure (CPAP) treatment initiation impairs CPAP adherence. Allergic rhinitis is associated with worsening nasal congestion in patients who are exposed to nonallergic triggers. Use of CPAP presents potential nonallergic triggers (eg, humidity, temperature, pressure, and airflow). OBJECTIVE: To compare nasal congestion among CPAP users with allergic rhinitis, nonallergic rhinitis, and no rhinitis. We hypothesize that CPAP patients with baseline allergic rhinitis are more likely to experience a worsening of nasal congestion (or less improvement in nasal congestion) compared with patients with no baseline rhinitis. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study included consecutive patients newly diagnosed with obstructive sleep apnea in a tertiary sleep center who were using CPAP therapy 3 months after diagnosis. Baseline rhinitis status was assigned as allergic rhinitis, nonallergic rhinitis, or no rhinitis, based on questionnaire responses and past allergy testing. Data were collected from 2004 to 2008 and analyzed from July 2019 to February 2020. MAIN OUTCOMES AND MEASURES: At baseline before CPAP exposure and again 3 months later, subjective nasal congestion was measured with the Nasal Obstruction Symptom Evaluation (NOSE) scale and a visual analog scale (VAS), each scored from 0 to 100 (100 = worst congestion). Changes in nasal congestion were tested over 3 months for the whole cohort, within each rhinitis subgroup (paired t test), and between rhinitis subgroups (multivariate linear regression). RESULTS: The study cohort comprised 102 participants, of whom 61 (60%) were male and the mean (SD) age was 50 (13). The study included 23 (22.5%) participants with allergic rhinitis, 67 (65.7%) with nonallergic rhinitis, and 12 (11.8%) with no rhinitis. Nasal congestion improved from baseline to 3 months in the whole cohort (mean [SD] NOSE score, 38 [26] to 27 [23], mean [SD] change, -10 [23]; 95% CI, -15 to -6; mean [SD] VAS score, 41 [27] to 32 [28]; mean [SD] change, -10 [26]; 95% CI, [-15 to -4]) and in each rhinitis subgroup. Adjusted improvement in nasal congestion at 3 months was significantly less in the allergic rhinitis subgroup compared with the no rhinitis subgroup (positive difference means less improvement) compared with baseline: NOSE score 14 (95% CI, 1 to 28) and VAS score 15 (95% CI, 0 to 30). CONCLUSIONS AND RELEVANCE: Initiation of CPAP was associated with improved subjective nasal congestion, but less improvement in patients with baseline allergic rhinitis. Baseline allergic rhinitis may predict which patients are more vulnerable to potential congestive effects of CPAP.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Skirko JR, James KT, Shusterman DJ, et al. Association of Allergic Rhinitis With Change in Nasal Congestion in New Continuous Positive Airway Pressure Users. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32271366. doi:10.1001/jamaoto.2020.0261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。